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                                             ABSTRACT 
 
Background: 
The  study was undertaken to evaluate the expression of p63 and amelogenin 
in human tooth germs and ameloblastomas  by immunohistochemistry to find out 
whether the pattern of expression was related to differentiation of ameloblasts. 
Materials and Methods: 
In this study fifteen human tooth germs of late bell stage, six human tooth 
germs of early bell stage and fifteen ameloblastoma samples were included and 
expression pattern of p63 and amelogenin were evaluated individually in all the 
samples. 
Results: 
During the early bell stage, p63 expression was intense throughout the enamel 
organ. But, during the late bell stage, the number and intensity of p63 expression 
decreases in the cells of enamel organ. The peripheral cells in the ameloblastoma 
shows variable pattern of p63 expression. Expression of amelogenin was first evident 
in the presecretory ameloblasts at the cusp tip, followed by secretory ameloblasts  and  
progresses cervically. But in ten late bell stage tooth germs, amelogenin expression 
was negative in the secretory ameloblasts and positive only at the secreting end i.e. 
tomes process.  Intense staining was evident at the enamel matrix and in some 
dentinal tubules nearer to enamel matrix secretion. No amelogenin expression was 
evident in the dental papilla cells or odontoblasts throughout odontogenesis with the 
exception of dental follicle. Amelogenin expression was absent in eleven cases of 
ameloblastoma, but in four cases positive expression was evident at the peripheral 
cells. 
Conclusion : 
In the present study, the expression pattern of p63 and amelogenin in human 
tooth germ and ameloblastoma  correlates with cytodifferentiation of ameloblasts. 
Keywords : human tooth germ, ameloblastoma, immunohistochemistry,  p63,   
amelogenin,     
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IEE – Inner  enamel epithelium 
OEE – Outer enamel epithelium 
PA – Preameloblasts 
tPSA – Transitional presecretory ameloblasts   
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LBS – Late bell stage 
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IHC - Immunohistochemistry      
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INTRODUCTION 
   
 Human teeth develop after a series of tightly regulated, sequential steps. At 
about 7th week thickening of the dental epithelium starts to form the dental lamina 
or dental placode, the first stage in tooth development. Subsequently, the lamina 
invaginates into the underlining neural crest derived mesenchyme and assumes a 
‘‘bud’’ conformation, surrounded by condensed mesenchyme. Then the 
developing tooth matures into the cap stage, with the dental epithelium folding to 
embrace the mesenchyme. In this structure, the epithelium above the mesenchyme 
assumes a button-like morphology known as the enamel knot. The further shaping 
of the tooth germ results from asymmetric proliferation i.e, cells outside the 
enamel knot actively proliferate, while inner cells cease to proliferate and thus act 
like an anchor to enforce moulding of the cap stage. This asymmetric proliferation 
also splits the enamel knot into the inner and outer enamel knots; the mesenchyme 
adjacent to the inner knot will form the dental papilla, whereas that on the outside 
will develop into the dental follicle. Incisor teeth assume a conical shape at this 
stage and lose their enamel knot at the end of the cap stage. Molars have a more 
complex destiny, after loss of the first enamel knot, they develop secondary 
enamel knots, which shape the tooth into a multicuspid. ‘‘bell’’ stage. Finally, 
deposition of enamel by the epithelial derived ameloblasts and dentin by the 
mesenchyme-derived odontoblasts lead to the final mature tooth (1). 
 Ameloblastoma  is a benign but locally aggressive odontogenic tumor 
believed to arise from the odontogenic epithelium of tooth germ and presents  
with variable clinico-pathologic behavior and tendency for recurrence. 
Histologically, ameloblastoma shows considerable variation, including follicular, 
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plexiform, acanthomatous, granular cell, basal cell, and desmoplastic types which 
needs different management. 
 The p63 gene has a high degree of amino acid sequence homology to the 
p53 and p73 genes and produces at least six different proteins with distinct 
properties that affect the function of other p63, p53 and p73 proteins expressed in 
the same cell.  It has both amino- and carboxy terminals. At the C-terminal of p63, 
isofoms such as α, β, and γ exists. The N-terminal of p63 is characterized by two 
different isoforms viz; TA form (or transactivated form) and ΔN form (or 
truncated form).  TAp63  contains acidic N-terminal transactivation domain and 
ΔNp63  lacks this domain. Various isoforms of p63 has different roles. ΔNp63 
contributes to cell proliferation while TAp63 isoforms induce cell differentiation 
(2). Expression of p63 has been previously reported in human tooth germ  as well 
as  in ameloblastoma (3,4,5). Although several studies indicate the expression of  
p63 in the respective tissues, the pattern of expression in different types of cells in 
enamel organ is lacking. 
 Amelogenin is the predominant enamel matrix proteins involved in 
biomineralization  and organization of developing enamel. It functions by 
regulating  crystallite formation during the secretory stage of enamel 
development. Although several studies indicate the expression of amelogenin in 
different animal species such as rat, bovine, porcine and dog by using different 
techniques including immunohistochemistry, only three studies regarding the 
immunohistochemical pattern of expression of amelogenin in human tooth germs 
have been reported so far (6,7,8) to my knowledge. There are so many studies 
regarding the expression of amelogenin in ameloblastoma have been reported, but 
still the results are inconclusive (9,10,11,12). 
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 Therefore the present study is under taken to evaluate the expression of 
p63 and amelogenin in the inner enamel epithelial cell lineage and compare it with 
ameloblastoma.  
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AIM AND OBJECTIVES 
   
Aim :  
        To evaluate the expression of  immunohistochemical markers p63  and 
amelogenin in human tooth germ and ameloblastoma. 
Objectives: 
The objective of the study is to 
1. To compare the expression pattern of immunohistochemical markers p63 
and  amelogenin  in human tooth germ and ameloblastoma. 
2. To determine whether the pattern of expression is related to differentiation. 
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REVIEW OF LITERATURE 
   
I.  EXPRESSION OF P63 IN HUMAN TOOTH GERM  
 In 1999,  Parsa et al.  studied the expression of p63 in normal human 
epidermis, hair follicles, stratified  squamous epidermis and squamous cell 
carcinoma by immunohistochemistry and other techniques. Mouse monoclonal 
antibody to p63 clone 4A4 was used in the study. The author’s found out that p63 
expression was localized to the basal cells of keratinocytes and hair follicles. But 
the intensity of p63 expression varied in different cells of the basal layer. The 
basal cells which strongly stained for p63 were clustered in patches, separated by 
basal cells weakly stained or unstained. Moreover, p63 expression was absent 
from the spinous layer where terminal differentiation begins. In well differentiated 
squamous cell carcinoma p63 expression was confined to the nuclei of  basal cells 
arranged in a ring, at a distance from the centres of terminal differentiation. But, 
in poorly differentiated tumors the number of cells containing p63 increased and 
the distribution of p63 was disorganized with respect to the centres of terminal 
differentiation. The author’s concluded that p63 protein helped in maintaining the 
proliferative potential of cells and prevents it from terminal differentiation (13). 
 In 2000, Pellegrini et al. studied the expression of p63 and PCNA in the 
proliferative compartment of stratified squamous epithelia which consists of stem 
and transit amplifying (TA) keratinocytes by immunohistochemistry, clonal 
analysis and other techniques. A p63 specific mAb and PCNA specific mAb  were 
used in the study. The author’s found out that  by immuunohistochemistry, the 
basal cells with higher content of nuclear p63 were interspersed  by cells with 
little or no p63. The authors also found out that among the basal cells, some cells 
express both p63 and PCNA, some express PCNA but not p63 and some express 
                                                                                 Review of literature 
 
 Page 6 
 
p63 but not PCNA. By clonal analysis, the author’s found out that both p63 and 
PCNA expression were high in holoclones (consist primarily of stem cells), high 
levels of PCNA and low levels of p63 in meroclones (contain slightly more 
differentiated yet highly proliferative cells called transit- amplifying  (TA) cells) 
and PCNA expression alone in paraclones (consists of committed, terminally 
differentiating cells). From these findings the author’s concluded  that  p63 protein 
was principally restricted to keratinocyte stem cells (14). 
 In 2004, Cernochova et al. studied the expression of p53, p63 and p73 in 
the orofacial region such as  dental lamina, dental organ, dental papilla, dental 
follicle,  vestibular lamina, epithelium of the palate and palatal suture, 
differentiating mucosa of the dorsum of the tongue and  respiratory and olfactory 
regions of the developing nasal cavity  of five human embryos aged 7 -18 weeks 
of intrauterine development using a three step  immunohistochemical method 
using monoclonal antibodies. The author’s found  out  that the expression of p63 
in all the above said areas  increased from  seventh to eleventh week, where a  
maximum of positive nuclei was found and p63 expression dropped down from  
thirteenth week. A decrease in p53 and p73 proteins also occured in the 13-week-
old material with the exception of the tooth germ where a drop in p73 appeared in 
the ninth week (15). 
 In 2005, Kumamoto et al. studied the expression of p63 and p73 in 
human tooth germs and ameloblastoma by immunohistochemistry and reverse 
transcriptase polymerase chain reaction. Mouse anti p63 monoclonal antibody in 
1:100 dilution and rabbit anti p73 polyclonal antibody in 1:500 dilution were used 
in the study. The author’s found out that the p63 expression was evident in most 
cells of outer and inner enamel epithelium, dental lamina and fewer cells of 
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stratum intermedium and stellate reticulum. In ameloblastoma p63 expression was 
evident in most peripheral columnar or cuboidal cells and in some central 
polyhedral cells. The authors also found out that in both tooth germ and 
ameloblastoma p63 positive cells were more numerous than p73 positive cells in 
stratum intermedium and stellate reticulum. The authors concluded that p53 
homologs i.e. p63 and p73 played a role in the proliferation and differentiation of 
odontogenic epithelial cell (3). 
 In 2005, Kock et al. studied  the expression of the p63  in normal human 
tooth germs at different gestational stages by immunohistochemistry. Monoclonal 
mouse anti human p63 protein, clone 4A4  in 1: 50 dilution was used in the study. 
Incisors representing the cap stage were identified at GA 11 and 15 weeks  and 
incisor representing the bell stage with hard tissue formation was identified at GA 
21 weeks.  The author’s found out that expression of p63 was evident in the outer 
and the inner enamel epithelium, dental lamina as well as in the proliferating cells 
of the stratified epithelium in the overlying mucosa. at GA 11 and 15 weeks. In 
addition there was a strong expression of p63 in the enamel knot and at the stellate 
reticulum cells at GA 11 weeks, which was absent at GA 15 weeks. The author’s  
indicated that p63 might play a role in signaling in the morphogenesis of the 
human tooth. At GA 21 weeks, strong p63 immunostaining was evident at the 
outer and inner enamel epithelium, secondary dental lamina, proliferating cells of 
oral mucosa and weak staining was evident at the nucleus of stellate reticulum 
cells.  The  spatio-temporal expression of p63 indicated that p63 might play a role 
in the tooth formation (4). 
 In 2006, Laurikkala et al. studied the expression of p63 during tooth 
development in wild type embryos from E10 to postnatal day 3 using insitu 
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hybridization, immunohistochemistry and other techniques. Immunohistochemical 
analysis was done with antibodies that recognize all p63 isoforms (pan p63) and 
ΔNp63 isoforms.The primary antibodies used were anti-p63 (4A4,1:500) and anti-
ΔNp63 (sc-8609, 1:100).  During the initiation (E11), bud (E12) and cap (E15) 
stages of mandibular molar development, both pan-p63   and ΔNp63 expression 
were  seen throughout the dental epithelium, and it extended into the oral 
epithelium. At the bell stage (E17), pan-p63  and ΔNp63 expression were intense 
in the outer enamel epithelium, whereas the intensity of expression  reduced in the 
stellate reticulum and inner enamel epithelium  when it differentiated into 
ameloblasts. But, no expression of TAp63 was seen in the developing teeth. The 
author’s concluded that ΔNp63 was the major p63 isoform expressed during 
embryonic tooth development and  only one percent of all p63 isoforms 
represented the TA isoform. The author’s also concluded that  in the absence of 
p63, tooth development arrests at the dental lamina stage, suggesting that p63 is 
required in the ectoderm for the formation of  tooth (16). 
 In 2012, Matsuura et al.  determined  the role  of p51/63 isoforms in 
ameloblastic differentiation of mouse tooth germ  by RT-PCR and western 
blotting using epithelium of molar tooth germ cell lines established from a 
mandibular tooth germ of p53 deficient mice. The authors’ described that the 
expression of ΔNp51β/ΔNp63α (an isoform without transactivation domain), was 
detected at high level in immature cells, while the expression of TAp51/TAp63 
isoforms, (isoform with the transactivation domain), was detected at high level in 
mature cells. Moreover, induction of TAp51α/TAp63γ expression led to down-
regulation of ΔNp51β/ ΔNp63α expression and up-regulation of ameloblastin 
expression, a differentiation marker of amelogenesis. The authors’ concluded that  
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p63 has important role in regulation of the proliferation and differentiation of 
tooth germ epithelial cells and its contribution towards tooth development (17) 
 
II.  EXPRESSION OF P63 IN AMELOBLASTOMA 
 In 2006, Lo Muzio et al. evaluated  p63 expression in the epithelial lining 
of different odontogenic tumors such as unicystic ameloblastoma, solid 
ameloblastoma, peripheral ameloblastoma, ameloblastic carcinoma, adenomatoid 
odontogenic tumor, calcifying odontogenic cyst, primary intraosseous carcinoma 
and clear cell odontogenic carcinoma by immunohistochemistry for a better 
understanding of its biological role in oncogenesis. Monoclonal mouse anti-
human p63 protein, clone 4A4 raised against aminoacids 1-205 of the N- terminal 
portion of human ΔNp63 protein (does not recognize TAp63 isoforms) was used 
in the study. The authors’ described that p63  expression was found  in the cells of 
basal layer and in most cases both in the cells of basal as well as superficial layer 
of unicystic ameloblastoma  and in the peripheral as well as central epithelial cells 
of solid ameloblastoma, recurrent ameloblastoma and ameloblastic carcinoma. 
The authors’ concluded that benign odontogenic, locally aggressive tumours with 
a high risk of recurrence exhibited statistically higher p63 expression than benign 
odontogenic, non-aggressive tumours with a low risk of recurrence. However, p63 
expression did not significantly differ between benign,  locally aggressive 
odontogenic tumour with a high risk of recurrence and malignant odontogenic 
tumour (18). 
 In 2007,   Gratzinger et al. evaluated the expression of p63,calponin, CK 
7, CK 5/6, GFAP, SMA, S100 in odontogenic tumors such as ameloblastoma, 
calcifying epithelial odontogenic tumor, glandular odontogenic cyst, and  
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keratocystic odontogenic tumor. Mouse monoclonal, clone 4A4, p63 antibody in 1 
: 200 dilution was used in the study. The authors’ described that  both CK 5/6 and 
p63 were strongly expressed in the basal half of the oral  epithelium and generally 
not expressed in the mature superficial layers. This polarized loss of expression of 
p63 in superficial layers of oral epithelium  is absent in solid odontogenic 
neoplasms such as ameloblastoma and CEOT, but  is maintained in the cystic 
lesions such as KOT and GOC (5). 
 In 2008, Gurgel et al.  investigated the immunohistochemical expression 
of  Ki-67, p53 and p63 in keratocystic odontogenic tumors (Nevoid basal cell 
carcinoma syndrome, sporadic KOTs, primary KOTs and recurrent KOTs ) in 
order to contribute to the biological profile of the tumor. Monoclonal antibody  
against p63, clone 4A4 (recognizes both TAp63 and ΔNp63 isoforms ) was used 
in the study. The authors’ described that p63 was expressed more intensely in all 
epithelial layers of  KOT with no difference in immunostaining observed between 
primary and recurrent KOTs or between NBCCS and sporadic KOTs.. The 
author’s concluded that the p63 plays a role in the regulation of epithelial cell 
differentiation, and may favor tumorigenesis (19). 
 In 2011, Seyedmajidi et al. evaluated the expression of p63 in 
odontogenic cysts such as dentigerous cyst, radicular cyst and keratocystic 
odontogenic tumor based on the differences in their clinical behavior by 
immunohistochemistry. The monoclonal mouse anti-human p63 protein, clone 
4A4 was used in the study. The authors’ described that the intensity of staining  by 
p63 was greater in the nucleus of epithelial cells lining   KCOT in comparison 
with radicular cyst and dentigerous cyst. The authors’ concluded that the higher  
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expression of p63 in KCOTs, could be useful to explain the difference in the 
clinical and pathological behavior of KCOTs (20). 
 In 2013,  Moghadam et al.  investigated the immunohistochemical 
expression of p63  in odontogenic cysts and tumors such as odontogenic 
keratocyst, ameloblastoma, radicular cyst, dentigerous cyst and calcifying 
odontogenic cyst. P63 monoclonal antibody, clone 4A4 ( Code N 1604 that 
recognizes Np63 isoforms) in 1:25 dilution was used in the study and  p63 
positive cells was calculated in the lining of  odontogenic cysts and islands of 
ameloblastoma.  The authors’ described that all lesions showed intense reactivity 
in the odontogenic epithelium, as it was  expressed through out the lining 
epithelium of odontogenic keratocyst except the surface parakeratinised layer, all 
layers of  epithelial cells in calcified odontogenic cysts,  basal and parabasal layers 
of radicular  and dentigerous cysts (upper layers show weaker expression)  and in 
peripheral cells of ameloblastoma except stellate reticulum which shows weaker 
immunostaining.  They concluded that  p63 protein is important in the 
proliferation and differentiation of odontogenic epithelial cells  but it could not be 
a useful marker  to differentiate  between  aggressive and non aggressive lesions. 
They also concluded that p63 can be a basal cell marker  as it was not expressed in 
mature differentiated cells (21). 
 In 2014, Varsha  et al. investigated the expression of p63 in odontogenic 
lesions such as odontogenic keraocyst, solid ameloblastoma, unicystic 
ameloblastoma Type I and Type III and follicular tissue by 
immunohistochemistry.  The authors’ described that p63 was expressed in the 
peripheral columnar  and central stellate reticulum – like polyhedral cells in 
ameloblastic islands of solid ameloblastoma. P63 expression was also seen in the 
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cystic lining of unicystic ameloblastoma Type I and Type III and intramural 
nodules in Type III ameloblastoma The authors’ concluded that  expression of p63 
in OKC was comparable with that of solid ameloblastoma and unicystic 
ameloblastoma type III and significantly  higher than that of unicystic 
ameloblastoma type I. They concluded that the higher expression of p63 in 
odontogenic lesions  correlates well with their aggressive behavior and thereby 
suggesting alterations in treatment modalities (22). 
 In 2015, Jaafari - Ashkavandi  et al.  investigated the expression of p63  
and Ki-67  in dentigerous cyst, unicystic and conventional ameloblastoma  using 
immunohistochemistry. Mouse monoclonal anti-p63 antibody (clone 7JUL) was 
used in the study. The authors’ described that the p63 was expressed in the basal 
as well as suprabasal layers  of luminal and mural types of  unicystic 
ameloblastoma and in the peripheral and central cells of follicular and plexiform 
subtypes of solid ameloblastoma. They found out that intensity of p63  expression 
was significantly higher in solid ameloblastoma and mural type of unicystic 
ameloblastoma than luminal type of unicystic ameloblastoma and dentigerous 
cysts. They concluded that the expression of p63 is directly related to the 
aggressive and invasive behavior of odontogenic lesions (23).  
 
III.  EXPRESSION OF AMELOGENIN IN HUMAN TOOTH GERM 
 In 1988, Kircham et al. did a study on maturation in developing 
permanent porcine enamel by assessing the mineral content per tissue volume and 
found out that the levels of mineralization correlated directly with the histological 
appearance of enamel organ. The author’s found out that the tall ameloblasts 
associated with the secretary stage of enamel development was characterized by 
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relatively low levels of mineral (30% by volume) and high levels of organic 
matrix. Relatively shortened ameloblasts associated with the transition stage was 
characterized by massive loss of organic matrix but mineral content did not rise 
significantly on a volume basis. Ameloblasts with 50% reduction in height, 
associated with the maturation stage of enamel development was characterized by 
total loss of organic matrix but the mineral content was relatively low on a volume 
basis. The author’s concluded that permanent porcine teeth erupt in a partially 
immature porous condition and thereafter the mineralization occurs by ingress of 
mineral ions from saliva (24). 
 In 1991, Inai et al. examined the synthesis and secretion of enamel protein 
by ameloblasts in the early stages of their development by immunohistochemistry 
in rat molar tooth germs. Immunohistochemical localization of amelogenin in the 
early stages of ameloblast differentiation was carried out at light and electron 
microscopic levels using amelogenin monoclonal antibody. The authors found out 
that the first appearance of amelogenin was detected in the presecretory 
ameloblasts prior to the breakdown of the basement membrane, whereas the 
expression of amelogenin was detected  both prior to and after the breakdown of 
the basement membrane in the odontoblasts. However, the intensity of the staining 
increased in the predentin, intercellular spaces of odontoblasts and  dental pulp 
cells after the breakdown of basement membrane, which indicated penetration of 
amelogenin from the presecretory ameloblast layer to the dental pulp. On the other 
hand, the staining in the odontoblast layer decreased markedly and spot-like 
staining was detected in the predentin once the enamel matrix was secreted.  From 
these observations, the author’s concluded that the  penetration of enamel protein 
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toward the dental pulp and odontoblasts plays a role in the interaction between 
ameloblasts and odontoblasts (25). 
 In 1992,  Salido et al.  investigated the characterization of the AMGX and 
AMGY genes on the short arms of the human X and Y chromosomes which 
encode the amelogenins in the incisor tooth buds from six human fetuses ranging 
from 19 to 24 wk of gestation by fluorescence in situ hybridization. The author’s 
found out that the  AMGY locus on the Y chromosome  also encodes a functional 
protein, although its level of expression was only 10% of that of the AMGX locus 
on the X chromosome (26). 
 In 1996, Inage et al. studied the gene expression and localization  of 
amelogenin in the developing rat incisor by insitu hybridization and 
immunohisotchemistry.  Polyclonal antibody against bovine amelogenin and 
antibody against C telopeptide of amelogenin were used in 
immunohistochemistry. The author’s found out that both by insitu hybridization 
and immunohistochemistry, a  weak reaction for amelogenin was evident in the 
inner enamel epithelium of the cervical loop and the expression became more 
intense in the cytoplasm of secretory ameloblasts, ameloblasts in the terminal 
secretion and transitional zones. The expression became weak in the shortening 
ameloblasts and at the ruffled border of the ruffle ended ameloblasts in the 
maturing zone and it  became negative in the smooth ended ameloblasts in the 
maturing zone. No expression  was found in the cells of the stratum intermedium 
and stellate reticulum throughout amelogenesis (27). 
 In 1997, Karg et al. studied the expression of amelogenin in embryonic 
and neonatal hamster teeth by in situ hybridisation and immunohistochemistry. 
During the bell stage, expression of amelogenin  both by in situ hybridisation and 
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immunohistochemistry was detected in the presecretory ameloblasts, predentine 
and between odontoblasts. However,  the expression was limited to the secretory 
ameloblasts and as well as transitional/ maturation ameloblasts once enamel is 
formed. The authors conclude that expression of amelogenin marks the 
differentiation of PSA, but is not expressed in the mesenchymal component of the 
tooth germ (28). 
 In 1997, Zeichner David et al. studied the timing of expression of enamel 
protein tuftelin in relation to amelogenin in developing mouse molars by 
immunohistochemistry, PCR and other techniques. The  author’s found out that by 
immunohistochemistry, tuftelin expression was first detected  at E17 in the 
preameloblasts where it is synthesized and secreted into the developing 
extracellular matrix and dental papilla mesenchymal cells. In contrast, amelogenin 
expression was first detected at E19 in the polarized, non dividing, fully 
differentiated ameloblast cells. But mRNA transcripts of tuftelin was first detected 
at E13 (equivalent to bud stage of tooth development) and amelogenin transcripts 
was first detected at E15 (equivalent to early cap stage of tooth development). The 
author’s concluded that the discrepancy between transcript detection and 
translation product detection might represent a difference in method sensitivity 
i.e., PCR is extremely sensitive, whereas immunodetection requires a larger 
number of molecules for detection (29). 
 In 1999, Papagerakis et al. studied the expression on amelogenin mRNA 
in rat incisors by insitu hybridization and other techniques and compared the 
expression pattern with vitamin-D deficient rats. The author’s found that 
amelogenin mRNA was highly expressed in differentiated ameloblasts during the 
secretion stage as well as the maturation stage. In addition, amelogenin mRNA 
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was also detected in apparently smaller amounts in pre-ameloblasts located near 
the apical loop. No amelogenin  mRNA expression was detected in the 
odontoblasts. But the steady state levels of amelogenin mRNA was decreased in 
vitamin -D deficient rats and an upregulation of mRNA expression was noted in 
the animal tissue section injected with 1,25-dihydroxyvitamin D3 (1,25(OH)2D3).  
From these findings the author’s concluded that amelogenin gene expression is 
regulated by vitamin D (30). 
 In 1999, Wakida et al. studied the expression of amelogenin in maturation 
stage ameloblasts of porcine tooth germs by insitu hybridization and 
immunohistochemistry and compared the expression pattern with rat tooth germs. 
Amelogenin antiserum in 1:1000 dilution was used in the study. The author’s 
found out that in the pigs, the secretory  ameloblasts showed immunoreactivity in 
the infranuclear and supranuclear cytoplasm and also intense immunoreactivity 
was found in the enamel matrix from the surface upto a depth of about 40 µm and 
deeper to this only a faint reaction was observed. In the transition stage 
ameloblasts, immunoreactivity was detected only in the infranuclear cytoplasm. 
Immunoreactivity of immature enamel under the transition stage ameloblasts was 
found to decrease gradually and disappeared at the end of this stage. At the early 
maturation stage, immunoreactivity was absent in the maturation ameloblasts as 
well as in the surface layer of immature enamel. Other cells of the tooth germ such 
as outer enamel epithelium, stratum intermedium and odontoblasts showed no 
immunoreactivity throughout the developmental stages. But in the rat tooth germ, 
immunoreactivity of amelogenin was detected in ameloblasts  till the early 
maturation stage by using the same  antiserum. The author’s  concluded  that the 
reason for persistence of enamel protein expression till the early maturation stage 
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in rodents was due to the rapid rate of enamel formation and continuously 
growing rat incisors compared with pigs. These results also indicated that  the 
secretory activity of the maturation ameloblast is varied depending upon animal 
species (31). 
 In 2000, Ravindranath et al. demonstrated that a conserved GMp  
mimicking peptide(N-acetyl-D-glucosamine mimicking peptide) motif of 
cytokeratins specifically binds to the amelogenin trityrosyl motif peptide (ATMP) 
and suggested that amelogenins are “cytokeratin14 (intermediate filament)-
binding proteins,” similar to plectin, nestin, and desmocalmin. Phosphorylation of 
serine 16 of amelogenins resulted in their dissociation from intermediate filament. 
From these findings the author’s postulated  that intracellular amelogenin-keratin 
binding may be functionally involved in inhibiting amelogenin assembly and that 
the reason for such interaction could be to facilitate amelogenin secretion  and 
also the polypeptide motifs, comparable with the cytokeratin GMp1, occur within 
currently unidentified matrix proteins and have a functional role in normal enamel 
biomineralization (32). 
 In 2001, Ravindranath et al.  demonstrated the  co-assembly of 
amelogenin-CK14 in the secretory ameloblasts, its migration from the perinuclear 
region  to the apical region of ameloblasts and it’s subsequent dissociation at 
Tomes’ process using confocal laser microscopy,. The author’s suggested that 
CK14 functions as a chaperon for nascent amelogenin polypeptides during 
amelogenesis (33). 
 In 2001, Hu et al. studied the expression of amelogenin and enamelin in 
developing molars of postnatal mouse by insitu hybridization. The author’s found 
out that the amelogenin mRNA  was first detected on preameloblasts  in the cusp 
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slopes on day 2 and continued till day 14 throughout the secretory, transition and 
early maturation stages and ceased at the CEJ at day 21. Amelogenin mRNA 
hybridization signals were not detected in odontoblasts or dental pulp, bone, 
stratum intermedium, stellate reticulum and outer enamel epithelial cells of the 
enamel organ and also along the developing root (34). 
 In 2002, Oida et al. studied the expression of amelogenin mRNA in 
porcine tooth germs by RT-PCR. The author’s found out that the amelogenin gene 
expression was detected in the secretory ameloblasts only after 20 cycles of PCR. 
However, when the PCR was carried out for 30 cycles, amelogenin gene products 
were found in the secretory and maturation stage ameloblasts, as well as in the 
odontoblast layer and a little expression was  also detected in dental pulp cells.  
But, no amelogenin amplification products were detected in oral epithelium cells, 
connective tissue cells and  muscle cells after 30 cycles. However, a trace of 
amelogenin gene expression was detected  in the oral epithelium sample only after 
40 cycles. The author’s concluded that the secretory ameloblasts expressed  
amelogenin at a rate over 1000 times than that of odontoblasts. The positive 
reaction in the odontoblast layer was attributed to background staining (35). 
 In 2003, Hatakeyama et al. studied the expression of RANKL in wild-
type controls and amelogenin- null mice by RT-PCR and immunohistochemistry. 
They reported that two mRNA splice forms of amelogenin, M180 and LRAP 
(Leucine Rich Amelogenin Peptide) were expressed  in cementoblast/PDL cells of 
wild-type mice (control). However in amelogenin-null mice  the expression of 
these two mRNA splice forms of amelogenin  were absent.  In addition,  the 
amelogenin-null PDL cells showed more intense staining for RANKL near the 
bone and cementum surface, suggesting that the amelogenin  played  a key role in 
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the maintenance of cementum through the RANKL/RANK mediated 
osteoclastogenic pathway (36). 
 In 2003, Nagano et al. examined, semi-quantitatively the mRNA levels of 
various enamel proteins such as  amelogenin, enamelin, sheathlin (ameloblastin/ 
amelin), enamelysin (MMP-20), and KLK4 (EMSP-1) in enamel organ epithelia  
and odontoblasts  at different developmental stages of porcine permanent tooth 
germs by in situ hybridisation. In this study, the ratio of amelogenin mRNA for 
secretory EOE (SA), maturation EOE (MA), young odontoblast (YO), and mature 
odontoblast (MO) samples was found to be  4096:2:64:1. The author’s concluded 
that, in the pig,  the secretory ameloblasts express  amelogenin mRNAs at levels 
thousands of times higher than do maturation ameloblasts and odontoblasts lining 
dentin beneath maturing enamel, and hundreds of times higher than do 
odontoblasts lining dentin beneath secretory-stage enamel. From these findings  
the author’s demonstrated that  amelogenin mRNAs  were expressed also  by 
odontoblasts  and suggested that they might play a role in the formation of dentin 
at the EDJ (37). 
 In 2003, Papagerakis et al. studied the  developmental expression pattern 
of amelogenin in the odontoblasts of rat tooth germs  through various in vitro and 
in vivo approaches at both the mRNA and the protein level. The author’s found 
out that amelogenin expression was detected  not only in the ameloblasts, but also 
in the young odontoblasts and stratum intermedium, concomitant with the 
deposition of mantle dentin. Once the formation of mantle dentin was complete, 
expression of Amel had  diminished progressively within the maturing 
odontoblast and stratum intermedium cell layers. In contrast, amelogenin 
expression was not found in the preodontoblasts, mature odontoblasts, dental pulp 
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cells and odontoblasts associated with root formation.  The author’s concluded 
that  the odontoblasts express Amel in a highly restricted development-dependent 
pattern associated with early mantle dentin formation  and it had been 
characterized as a useful marker to distinguish different stages of odontoblast cell 
lineage (38). 
 In 2004, Denbesten et al.  characterized a culture system to identify the 
human primary enamel organ epithelial cells  and evaluated the expression of 
cytokeratin 14, amelogenin, ameloblastin, enamelin, MMP- 20, KLK-4 by RT-
PCR. Tooth organs dissected from approximately 21 week old human fetal 
cadaver tissues was used in the study. The pooled tooth organs were washed in 
phosphate buffered saline, digested with 2mg/ml of collagenase/ dispase and 
cultured in supplemented keratinocyte media KGM-2  with or without serum and 
with different calcium concentrations. The authors’ described that the cells 
isolated from this media were mixture of cobblestone ameloblast like cells  and 
spindle shaped cells. The cobblestone ameloblast like cells were found to be 
immunopositive for cytokeratin 14, amelogenin, ameloblastin, enamelin, MMP-20 
and KLK-4 by RT-PCR. The spindle cells are likely to be derived from 
mesenchymal cells and they are not immunopositive for cytokeratin 14. They also 
described that the increasing calcium concentration in the culture increases the 
presence of spindle shaped cells and formation of nodules. They suggested that 
analysis of  mRNA with cDNA array  for osteoblast/ odontoblast related mRNA 
confirmed  that these cells  did not synthesize  type I collagen or other 
noncollagenous matrix proteins characteristic of osteogenesis (odontogenesis) 
related cells (39). 
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 In 2005, Quintana et al. studied the expression of amelogenin and 
ameloblastin in developing molars of mice from postnatal days 1-15 by insitu 
hybridization. The author’s found out that the amelogenin mRNA was detected in 
the secretory ameloblasts on the cusptip at day 3 and continues till day 7, after 
which the level of amelogenin mRNA gradually decreased, and at day 10 the 
expression was completely absent.  The author’s concluded that the amelogenin 
expression disappeared by the time the ameloblast morphology indicates the 
beginning of the maturation stage and ceases at the cementoenamel junction (40). 
 In 2006, Yan et al.  characterized a  culture system to identify 
differentiated ameloblast-lineage cells and evaluated the expression of cytokeratin 
14, amelogenin and ameloblastin  in  human  ameloblast- lineage cells for their 
synthesis of matrix proteins by immunoflourescence technique. Tooth organs from 
19–24-wk-old human fetal cadavers were either frozen and cryosectioned for 
immunostaining, or digested in collagenase/ dispase for cell culture. Protein A 
affinity -  purified antibody developed in rabbit  exposed to recombinant  human 
amelogenin in 1 : 2000 dilution was used in the study. Epithelial clones with two 
distinct morphologies, including smaller cobblestone-shaped cells and larger (5–
15 times in size) rounded cells were formed. Both cell types stained for 
cytokeratin 14 indicating the epithelial phenotype of these culture cells and the 
larger cells appeared more differentiated, showing stronger staining for 
amelogenin and ameloblastin. The authors’ also described that the expression of 
cytokeratin 14 begins to decrease  as the expression of amelogenin increases and 
suggested that cobblestone- shaped cells  are derived from undifferentiated enamel 
epithelium (inner and outer), and the larger cells are characteristic of 
preameloblast and ameloblast like cells (41). 
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 In 2006, Ye et al. studied the expression of amelogenin in human 
developing and mature dental pulp tissue by in situ hybridization, 
immunohistochemistry and other techniques.  The author’s found out that 
amelogenin expression was evident in the developing dentin of a developing tooth 
organ where enamel matrix  had not formed yet and also in  the odontoblast layer 
of  the adult human dentin. From these results the author’s suggested that  
amelogenins might not directly interact with pulp cells during development, but 
they had a role in epithelial/mesenchymal interactions related to enamel and 
dentin formation (42). 
 In 2007, Haze et al. studied the expression of amelogenin in long bone 
cells, cartilage cells and in bone marrow progenitor cells by insitu hybridization 
and indirect immunohistochemistry in rats and dogs.  LF-108, a polyclonal rabbit 
amelogenin antibody, raised against a synthetic peptide corresponding to 10 
amino acids at the C-terminus of human amelogenin (cross-reacts with dog and 
rat, diluted to 1/1000 for rat tissues and 1/2000 for dog tissues) and 110BQ, a 
monoclonal mouse antibody raised against human amelogenin (diluted to 1/1000)  
were used in the study.  Amelogenin mRNA and protein were found to be  
expressed in long bone periosteum, which is composed of progenitor cells, bone 
marrow cells, osteoblasts and osteoclasts lining the bone trabeculae and by some 
osteocytes. Amelogenin mRNA and protein were also found to be expressed in  
articular cartilage chondrocytes, epiphyseal bone cells, and differentially in 
specific cell layers of the epiphyseal growth plate.  From these findings the 
author’s  suggested that amelogenin has a crucial role in the processes of bone 
development and remodeling (43). 
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 In 2009, Cohen et al.  focused on the spatio-temporal expression of 
amelogenin in different tissues of the developing embryonic mouse craniofacial 
complex, such as the tooth germ, brain, eye, ganglia, peripheral nerve trunks, 
cartilage and bone using immunohistochemistry. The  antibodies used were: (a) 
270- Polyclonal rabbit antibody, raised against amelogenin N-terminus (identical 
in mouse, human etc.)  diluted in Phosphate buffered saline to 1:500 - 1:1000. (b) 
859 polyclonal rabbit antibody raised against rat amelogenin. The  authors’ 
described that amelogenin is expressed in various tissues of the developing mouse 
embryonic craniofacial complex such as brain, eye, ganglia, peripheral nerve 
trunks, cartilage and bone, and is first expressed at E10.5 in the brain and eye, 
long before the initiation of tooth formation. Application of amelogenin 
(recombinant human amelogenin protein) beads together with DiI, on E13.5 and 
E14.5 embryonic mandibular mesenchyme and on embryonic tooth germ, 
revealed recruitment of mesenchymal cells. The authors’ concluded  that 
amelogenin is expressed in many tissues of the cranio-facial complex during 
mouse embryonic development and differentiation, pointing to the possibility that 
it might be a multifunctional protein (44). 
 In 2011, Nel et al. studied the immunohistochemical expression of 
amelogenin in odontogenic epithelium of  developing dog teeth. Amelogenin (FL-
191, Santa Cruz Biotechnology) in 1:50 dilution was used in the study. The 
author’s found out that  amelogenin staining was not found at the bud and cap 
stage of tooth development, but during the late bell stage small amounts of 
amelogenin staining was observed  in the presecretory ameloblasts in close 
approximation to the cell nucleus. All secretory ameloblasts show diffuse granular 
staining for the amelogenin protein. In contrast amelogenin staining was not 
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detected in the IEE, OEE, stellate reticulum, stratum intermedium, dental laminae, 
Serres rests, or alveolar epithelium. Also no staining was observed in and around 
odontoblasts at advanced stages of odontogenesis, but the odontoblasts that were 
associated with the mantle dentin stained with amelogenin. The author’s 
concluded that amelogenin was a promising marker to distinguish between 
odontogenic and nonodontogenic tissues in dogs (45). 
 In 2011, Gutierrez-Cantu et al. studied the extracellular and intracellular 
spatial distribution of amelogenin and enamelysin in the enamel organ of the 
human tooth germ during its development by immunoflourescent labeling using  
confocal microscope. During the early bell stage amelogenin labeling was seen 
more than enamelysin, as free immunereactive granular patches towards basal 
membrane between ameloblast and odontoblast. Increased amelogenin expression 
and secretion  was found towards extracellular matrix formation region whereas 
enamelysin distribution was  only perinuclear in early bell stage. But, during the 
late bell stage decreasing amelogenin labeling was found in contrast with 
enamelysin, suggesting specific temporal amelogenin degradation. Enamelysin 
expression  was evident in  the ameloblast and stellate reticulum cytoplasm 
whereas, amelogenin  expression was observed inside ameloblasts, stellate 
reticulum, and stratum intermedium cells in the enamel organ as well as in the 
newly formed dentin extracellular matrix (7). 
 In 2012, Landin et al. studied the expression of genes such as amelogenin, 
ameloblastin and enamelin during early (presecretory stage) stages of  murine 
tooth development (i.e.) starting at the 11th embryonic day and ending at 7th day 
after birth by microarray analysis, insitu hybridization, real time PCR and western 
blotting. The author’s found out that in all the above mentioned methods Ambn, 
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Amelx, and Enam had similar expression pattern throughout the developmental 
stages, showing low pre-natal levels of expression compared to post-natal levels.    
Although expression  levels of Ambn, Amelx, and Enam were lower during early 
tooth development compared to secretory stages, enamel proteins were detectable 
by Western-blotting (46).  
 In 2013, Zheng et al. conducted a study and found out that clock genes 
direct ameloblast function by controlling several ameloblast-specific genes 
including amelogenin (marker of secretory ameloblasts) and klk4 (marker of 
maturation ameloblasts) at RNA and protein level. The author’s found out that 
amelogenin and klk4 undergo a regular 24 hr oscillations. This circadian rhythm 
was evident in the human enamel as cross-striations traversing enamel prisms. The 
authors also suggested that higher level of amelx protein expression occurs in 
phase with the awake status of rodents i.e) 10p.m. to 10a.m. The author’s 
concluded that  genetic modification in clock genes could account for variation in 
enamel characteristics such as shape, thickness and hardness among individuals 
(47). 
 In 2014, Mitsiadis et al. studied the expression of amelogenin protein in 
human developing, injured and carious teeth by immunohistochemistry. Human 
fetus tissues in 18-30 gestational week and rabbit polyclonal antibody against 
mouse amelogenin in 1:1000 dilution were used in the study. During the early bell 
stage (18th – 21st gestational week) amelogenin staining was evident at the 
differentiating IEE cells at the cusp tip, newly deposited predentin, proliferating 
inner enamel epithelial cells of the cervical areas and few stratum intermedium 
and stellate reticulum cells. During the late bell stage (30th gestational week) 
strong amelogenin staining was evident at the  functional ameloblasts (secreting 
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enamel matrix), differentiating odontoblasts and to a lesser extent in the cells of 
outer enamel epithelium. In the enamel matrix a zebra like pattern of amelogenin 
protein distribution was observed i.e.) two amelogenin positive layers at the ends 
splitted by an amelogenin negative zone. The author’s concluded that the zebra 
like pattern of amelogenin protein distribution in the enamel could be due to 
differential amelogenin processing during the secretory stage (6). 
 In 2015, Gasse et al. studied the expression of four enamel matrix protein 
genes amelogenin, ameloblastin, enamelin and amelotin during amelogenesis in 
the lizard by in situ hybridization.  The author’s found out that the AMEL 
expression was first evident  in  the secretory ameloblasts located at the cusp tip 
during early enamel matrix deposition.  But, during the maturation stage AMEL 
expression was absent  in the ameloblasts at the tooth tip but was still present in 
those towards the tooth base, on which enamel matrix is still deposited. In 
addition, AMEL transcripts were also detected in the odontoblasts facing the 
recently deposited predentin matrix at this stage. Also, when the tooth was nearly 
functional AMEL transcripts were no longer detected in the reduced ameloblasts, 
but were still faintly present in odontoblasts in the upper region of the pulp cavity 
(48). 
 In 2016,  Kim et al. studied the differential expression of amelogenin, 
enamelin and ameloblastin  proteins in rat tooth germ development by western 
blotting and  immunoflourescence.  Rabbit polyclonal antibody  against 
amelogenin was used in the study.  In western blotting the author’s found out that 
the expression of both amelogenin and enamelin  began at the crown stage and 
increased in an time dependent manner. In contrast, the expression of ameloblastin 
began at the early bell stage and maintained  it’s expression till the root stage.  In 
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immunofluorescence, expression of amelogenin was evident in the tall columnar 
preameloblasts/ ameloblasts  and in the secretory ameloblasts  at the crown stage. 
But, the expression of amelogenin in the secretory ameloblasts  stopped, when the 
enamel began to mature.  In addition,  amelogenin expression was also  evident 
occasionally in the preodontoblasts or odontoblasts but not in the dentin matrix 
(49). 
 In 2016, Frasheri et al. did a research with the title as “full length 
amelogenin influences the differentiation of human dental pulp stem cells”. The 
author’s treated human DPSCs with amelogenin at a concentration of 10ng/ml, 
100ng/ml and 1000 ng/ml and compared it with the unstimulated control in terms 
of cell morphology, proliferation, mineralization and gene expression for 
ALP(alkaline phosphatase), DMP-1 (dentin matrix protein -1) and DSPP (dentin 
sialophospho protein). The author’s found out that the proliferation of human 
DPSCs at 2 weeks was significantly reduced in the presence of highest 
concentration of amelogenin when compared to the unstimulated control. From 
these findings the author’s suggested that full length amelogenin influences 
differentiation of human DPSCs in relation to various concentrations (50). 
 In 2016, Mazumder et al. studied the spatial interaction of amelogenin 
and ameloblastin around maturing enamel rods by immunochemical analysis. 
Chicken anti-amelogenin (Amel-FL [amelogenin full-length antibody],  goat anti-
amelogenin (Amel-C19 [amelogenin C-terminal antibody],goat antiamelogenin- 
Nt (Amel-Nt [amelogenin N-terminal antibody], rabbit anti-ameloblastin (Ambn-
M300 [ameloblastin C-terminal antibody] and goat anti-ameloblastin (Ambn-N18 
[ameloblastin N-terminal antibody] were used in the study. The results revealed 
that the Amel-FL and Amel-Nt immunostained the entire thickness of enamel 
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matrix while Amel-C19 stained only the matrix adjacent to the secretory face of 
ameloblasts. Immunostained with Ambn-M300 revealed that the cleaved 
fragments generated from major C-terminal processing leave the enamel layer, 
while immunostaining with Ambn-N18 showed that the N-terminal portions of 
ameloblastin persist for longer periods in the enamel layer.  These results 
suggested that N-terminal proteolytic products of ameloblastin and amelogenin   
colocalized around enamel rods, forming a “fish net” pattern of the matrix 
throughout the enamel thickness (51). 
 In 2017, Gutierrez-Cantu et al. studied the expression of enamel proteins 
amelogenin and enamelysin in rough endoplasmic reticulum and golgi complex in 
human dental germs by histochemistry.  Anti amelogenin polyclonal antibody 
prepared from amelogenin of 11 day old rats in 1:1000 dilution was used in the 
study. The author’s  found that in early stages a colocalization of both proteins 
was found  inside the Golgi apparatus with amelogenin being more evident in 
relation with golgi complex and in late stages, a colocalization   of both proteins 
was found in the rough endoplasmic reticulum with enamelysin being more 
evident in relation with rough endoplasmic reticulum. The author’s also 
demonstrated  the presence of amelogenin and enamelysin in odontoblast and 
ameloblast and in dental papilla cells. However, the presence of these two proteins 
in odontoblast and dental papilla cells  remain unknown.The author’s suggested 
that the amelogenin expression in papilla  could be due to degradation of 
amelogenin by enamelysin, and these are nothing but the  rests of amelogenin in 
dental papilla cells (8). 
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IV.  EXPRESSION OF AMELOGENIN IN AMELOBLASTOMA 
 In 1991, Mori et al. evaluated the immunohistochemical expression of 
amelogenin in odontogenic cysts and tumors such as ameloblastomas, granular 
cell ameloblastomas, adenomatoid odontogenic tumours, ameloblastic fibromas, 
squamous odontogenic tumours and odontomas. A monoclonal antibody mAb to 
bovine amelogenins (IgM) in 1:1000 dilution was used. The authors’ described 
that amelogenin was expressed more intensely in the peripheral cells of follicular 
ameloblastomas, granular cells in granular ameloblastoma, pseudoglandular and 
ductal structures of adenomatoid odontogenic tumor, non-keratinized tumour cells 
of squamous odontogenic tumor, epithelial cells of ameloblastic fibroma, 
eosinophilic amorphous material and tumour cells of  CEOT, ghost cells of COC 
and reduced ameloblasts of odontoma. The  results of the study indicate that 
amelogenin is not only expressed in ameloblastoma but also in other odontogenic 
tumours and as well as in the eosinophilic amorphous matrix and ghost cells (52). 
 In 1992, Snead et al.  investigated the gene expression parameters for 
human ameloblastomas with the techniques of  mRNA  phenotying such as RT-
PCR,  insitu hybridization and northern blot analysis. The author’s  observed that 
both strands of the human amelogenin genes are transcribed by epithelia of the 
ameloblastoma, which results in the detection of RNAs that correspond to either 
the sense or antisense orientation. But in developing mouse molars, the sense 
orientation of the amelogenin probe fails to produce hybridization signals. The 
author’s concluded that in ameloblastoma the antisense RNA had the ability to 
bind to the sense strand of mRNA thus preventing it from being translated to 
proteins and this might account for the inability of ameloblastoma to produce 
matrix (53). 
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 In 1992, Saku et al.  analysed the expression of amelogenin and enamelin 
in odontogenic tumours such as ameloblastoma AOT, CEOT and COC  and 
compared with that of expression of keratin. Twenty human tooth germs of 
various stages, from bud stage to the early stage of apposition and mineralization 
of enamel and dentin and twenty bovine tooth germs with mineralization  were 
used as control. The antibodies to amelogenin and enamelin were prepared from 
immature enamel of bovine tooth germs and were raised in rabbits and purified by 
passing through columns of antigen coupled Sepharose 4B. The authors’ 
described that the  amelogenin and enamelin were expressed intensely in the 
cytoplasm of secretory ameloblasts  and in the extracellular enamel matrix of 
tooth germs. Keratin was expressed in the ameloblasts irrespective of the stages of 
maturation but, enamel matrix was not stained with antikeratin antibodies in tooth 
germ. In ameloblastoma, neither amelogenin nor enamelin was expressed in either 
the extracellular matrix or the tumor cells of basal- columnar and stellate types. 
Keratin was expressed intensely in most of the tumor cells especially those located 
in the centre of tumor cell nests.  The author’s concluded that negative 
immunostaining in ameloblastoma was due to the  absence of participation of  
ameloblasts in the histogenesis of ameloblastoma and the ameloblastoma cells are 
too immature  to express a detectable amount of enamel proteins (54). 
 In 2001, Kumamoto et al.  detected the immunohistochemical expression 
of amelogenin and cytokeratin 19 in epithelial odontogenic tumors such as 
ameloblastomas, calcifying epithelial odontogenic tumors, clear cell odontogenic 
tumors and malignant ameloblastomas and compared with that of five human 
tooth germs (crown mineralization stage) and ten non-odontogenic epithelial 
tumours.  Rabbit antibovine amelogenin polyclonal antibody in 1:200 dilution was 
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used in the study. The authors described that the amelogenin was expressed 
intensely in the peripheral columnar or cuboidal cells and in some central 
polyhedral cells of follicular and plexiform ameloblastoma, granular cells of 
granular cell ameloblastoma and less intensely in the basal cell ameloblastoma 
and desmoplastic ameloblastoma. Amelogenin was expressed diffusely in 
neoplastic cells and faintly in intercellular amyloid like material of CEOT and also 
it is faintly expressed in the neoplastic cells of  CCOT. In tooth germ amelogenin 
was expressed more intensely in the enamel matrix and inner enamel epithelium 
and less intensely in the stratum intermedium and stellate reticulum. Outer enamel 
epithelium, dental lamina of tooth germ and non-odontogenic epithelial tumours 
were negative for anti-amelogenin antibody (55). 
 In 2001, Abiko et al. investigated the immunolocalization of amelogenin  
in odontogenic tumours such as  ameloblastoma, adenomatoid odontogenic 
tumour, calcifying odontogenic cysts,  odontomas and primary intraosseous 
carcinoma   using an anti-amelogenin polyclonal antibody raised against bovine 
amelogenin in 1:200 dilution. The authors’ revealed that positive 
immunoreactivity for amelogenin was observed in adenomatoid odontogenic 
tumour, calcifying odontogenic cysts, primary intraosseous carcinoma and 
odontomas, but no such positive reaction was detected in ameloblastoma. The 
authors’ concluded that polyclonal anti-amelogenin antibody against bovine 
amelogenin used in this study  is useful for the determination of odontogenic 
tumours in which small mineralized foci are present in the epithelial nests (9). 
 In 2005, Chen et al. studied the expression of amelogenin and calcium 
transport proteins such as plasma membrane calcium pump and calbindin in ten 
conventional ameloblastoma (solid)  and tooth germ of rat mandible by 
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immunohistochemistry and the presence of calcium in tissue sections by von 
kossa. Polyclonal anti-amelogenin antibody prepared against the full-length 
recombinant M179 mouse amelogenin, which cross reacts with all known 
amelogenin isoforms  was used in the study at a dilution of 1:750. The authors’ 
described that the expression of amelogenin was minimal during the presecretory 
ameloblasts, but gradually increased during the secretory stage ameloblast 
suggesting that enamel matrix formation begins only after the presecretory stage 
in rat incisor tooth. In ameloblastoma amelogenin is expressed in both stellate 
reticulum-like cells and ameloblast-like cells, which suggests differentiation 
beyond the presecretory stage. Based on the similarity of expression of 
amelogenin in tooth germ and ameloblastoma, the authors’ conclude that  
ameloblastomas recapitulate a stage of differentiation beyond the presecretory 
stage. However, the mechanisms of extracellular matrix formation and 
mineralization associated with normal amelogenesis may be uncoupled in 
ameloblastomas (10). 
 In 2005, Tsujigiwa et al. analysed the expression of amelogenin in 
chromosome X and Y in both male and female patients with ameloblastoma by 
RT-PCR, in situ hybridization and immunohistochemistry. However, expression 
of amelogenin was detected with both RT-PCR and in situ hybridization 
techniques but not  with immunohistochemistry. The authors' also showed that all 
male patients with ameloblastoma displayed predominance of Y chromosome 
which is unlike the expression pattern in tooth germ. The authors' postulate that 
epigenetic alteration in chromosome may correlate with tumorigenesis in 
ameloblastoma (56). 
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 In 2011, Ren et al. investigated the gene expression profile of enamel 
matrix proteins and osteogenic associated proteins  in ameloblastoma, keratocystic 
odontogenic tumor and calcifying epithelial odontogenic tumor by 
immunohistochemistry, cell culture, RT-PCR, Insitu alkaline phosphatase activity. 
Antibodies for cytokeratin 14, amelogenin, ameloblastin, enamelin, and 
odontogenic ameloblast associated protein in 1 : 50 dilution were used in the 
study. The authors’ described that  all cell populations were positive for 
cytokeratin 14, confirming their epithelial phenotype. Among the enamel matrix 
proteins, more intense staining was seen for AMEL and ODAM A and less intense 
staining was seen for AMBN in all the tumors studied. In ameloblastoma and 
keratocystic odontogenic tumor amelogenin staining was intracellular whereas in 
calcifying epithelial odontogenic tumor, amelogenin stains the nuclei (57). 
 In 2012, Crivelini et al. evaluated the expression of  odontogenic 
ameloblast-associated protein (ODAM), amelotin (AMTN), ameloblastin 
(AMBN) and amelogenin (AMEL) by immunohistochemistry in samples of  
adenomatoid odontogenic tumor (AOT), calcifying epithelial odontogenic tumor 
(CEOT), developing odontoma, ameloblastoma, calcifying cystic odontogenic 
tumor (CCOT), ameloblastic fibroma (AF), myxoma, odontogenic fibroma (OF) 
and reduced enamel epithelia (REE). Mouse anti-human amelogenin  (AMEL) in 
1:500 dilution was the primary antibody used in the study. Ameloblastoma and 
CCOT were negative to amelogenin, both of which show ameloblast-like cells, 
while it was positive in the ameloblast-like cells of ameloblastic fibroma. In 
addition, amelogenin was negative in the ghost cells in CCOT and in mineralized 
tissue in AOT. The authors’ regard the lack of amelogenin expression in 
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ameloblastoma was due to undifferentiated state of the peripheral columnar cells, 
but were silent about the expression in ameloblastic fibroma (11). 
 In 2016, Anigol et al. evaluated the expression of amelogenin 
immunohistochemically in rat tooth germ, odontogenic epithelium of follicular 
tissue, odontogenic cysts and tumours such as dentigerous cysts, radicular cysts, 
solid/ multicystic ameloblastoma, unicystic ameloblastoma, desmoplastic 
ameloblastoma, squamous odontogenic tumor, adenomatoid odontogenic tumor, 
keratocystic odontogenic tumor, odontoma, calcifying cystic odontogenic tumor 
and ameloblastic carcinoma. Rabbit polyclonal antibody raised against AMELX/ 
AMELY  in 1 : 200 dilution was used in the study.  The authors’ described that 
the amelogenin was expressed in secretory ameloblasts and odontoblasts with 
moderate intensity, stellate reticulum with less intensity of rat tooth germ. They 
also described that amelogenin is moderately expressed in the peripheral 
ameloblast like cells compared with stellate reticulum like cells in all 
ameloblastomas except unicystic ameloblastoma where  amelogenin is more 
intensely expressed in basal layer (ameloblast like cells) and moderately expressed 
in stellate reticulum like cells. This explains the mature state of ameloblastoma 
like cells with high differentiation in unicystic ameloblastoma which correlates 
with its less aggressive clinical behavior. The authors’ concluded that the 
amelogenin expression in hard tissue formative lesions  indicate the advancing 
differentiation of the tissue. The diffuse and constant expression  in the epithelium  
predict the less likelihood of recurrence of the lesion (12). 
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MATERIALS AND METHODS 
   
 The research project was reviewed and approved by the Institutional 
Review Board/ Institutional Ethical Committee before the study. 
 Six spontaneously aborted  and  unclaimed dead fetal tissues from 12th  
week to 24th week was obtained from Institute of Obstetrics and 
Gynaecology, Chennai with prior permission. From these dead foetal 
tissues,  jaws were dissected and separated into upper and lower and 
segmented into left and right sections thus obtaining 24 samples. These 
samples, were decalcified in 8% HCl for one hour, fixed in 10% formalin, 
dehydrated, embedded in wax block and  sectioned sagitally in 3.5 microns 
thick serially cut sections. Among the 24 wax blocks which were obtained 
from the dead fetus tissues, twelve late bell stage (LBS) tooth germ 
sections  and six early bell stage (EBS) tooth germ sections were made and 
confirmed with histological observation. Along with this, three wax blocks  
of   late bell stage (LBS)   tooth germ were retrieved from the archival 
samples of Department of Oral Pathology and Microbiology, Tamil Nadu 
Government Dental College and Hospital, Chennai. 
 Fifteen archival samples of different histological variants  of 
ameloblastoma were retrieved from Department of Oral Pathology and 
Microbiology, Tamil Nadu Government Dental College and Hospital, 
Chennai and confirmed with histological observation. 
 Immunohistochemical markers purified anti-p63 antibody 4A4 clone 
(BioCare) and amelogenin (Biorbyt) were purchased and stored at 2-8˚ C 
in the refrigerator. 
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Materials Required: 
 Soft tissue rotary microtome – manual 
 Tissue floatation bath 
 Glass slides (both normal and APES coated) 
 Coplin jars 
 Cover slip 
 pH meter 
 Tissue paper 
 Induction stove 
 Pressure cooker 
 Weighing machine 
 Micropipette (1-10µl and 5-50µl) 
 Research microscope with photographic attachment 
Reagents used: 
 Hydrochloric acid 
 Formalin 
 Xylene 
 Alcohol 
 Distilled water 
 Hydrogen peroxide 
 PBS (Sodium Chloride (8gm), Potassium Dihydrogen Orthophosphate (1.5 
gm), Disodium Hydrogen Orthophosphate Anhydrous (8.5 gm) Distilled 
water 1000 ml at pH – 7.4) 
 Tween 20 
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  Citrate buffer (Tri- sodium citrate dihydrate (2.94 gm), 1N HCl (5ml), 
Distilled water (1000 ml) at pH -  6) 
METHODOLOGY: 
 Immunohistochemical staining was performed with the following markers, 
anti-p63  antibody (Mouse Monoclonal, clone 4A4, 1:25 dilution, CM163 
– BioCare, USA) and AMELX antibody (Rabbit Polyclonal, 1:200 
dilution, orb140077 – Biorbyt, UK) diluted in PBS, for 3.5 microns 
thickness foetus tissue sections and  ameloblastoma sections mounted on 
APES coated glass slides as per manufacturer’s instructions. 
 Sections were dewaxed and deparaffinized by three changes of xylene and 
hydrated through descending grades of alcohol. Endogenous peroxidase  
was blocked  in 3% H2O2 for 20 minutes and washed properly in distilled 
water 5 mins twice. Antigen retreival was done in pressure cooker at 120˚ 
C for 15 mins at  pH-6 (citrate buffer) and washed in distilled water 2 
changes - 5 mins each followed by PBS 3 changes – 5 mins each. Primary 
antibody in the above said dilutions was incubated for one hour  in a moist 
chamber at room temperature and washed in PBS 2 times, 2 mins each, 
followed by incubation with secondary antibody (Mouse/Rabbit 
Polydetector Plus DAB HRP Brown Detection System – BSB 0257- Bio 
SB, USA) as per manufacturer’s instructions. The sections were rinsed 
properly in distilled water and counterstained with   Ehrlich hematoxylin 
for 10 seconds, dehydrated in ascending grades of alcohol and mounted 
using DPX mountant. 
 Evaluation  was  done  based on staining as mild, moderate and intense in 
cells of interest by visual identification of the immunoreactivity in the 
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tissue sections using the Olympus Research Microscope (Model BX43F). 
In tooth germ the cells of the enamel organ such as inner enamel 
epithelium (IEE), preameloblasts (PA), presecretory ameloblasts (PSA) 
and secretory ameloblasts (SA) were selected and  observed for 
immunoreactivity. In ameloblastoma, the peripheral cells were selected 
because they resemble the normal development of enamel organ such as 
inner enamel epithelium (IEE), preameloblasts (PA), presecretory 
ameloblasts (PSA) and  secretory ameloblasts (SA).  
Immunohistochemical controls: 
 Oral squamous cell carcinoma (well- differentiated) was used as a positive 
control for p63. Human late bell stage tooth germ with formation of enamel matrix 
was used as a positive control for amelogenin.  For negative control the primary 
antibody was replaced by antibody diluent and confirmed to be unstained. 
 
 
  
 
Figure : Oral squamous cell carcinoma (well - differentiated) showing 
expression of p63 (control). 
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RESULTS 
   
Expression of p63 in human tooth germ and ameloblastoma 
Immunohistochemical expression of p63 was  intensely positive in the 
proliferating cells of the tooth bud, dental lamina, basal and supra basal cells of 
oral epithelium and skin epithelium and also in the basal cells of hair follicle and 
salivary duct. 
 
Early bell stage: 
 During the early bell stage, expression of p63 was intensely positive at the 
cervical loop, stratum intermedium, stellate reticulum and outer enamel 
epithelium. But, in the inner enamel epithelial lineage, as the cell  progresses from 
the cervical loop to the cusp tip, both the intensity and number of p63 positive 
cells decreases (Figure 1). 
 
Late bell stage: 
 During the late bell stage, expression of p63 was intensely positive  only at 
the cervical loop region.  In stellate reticulum, stratum intermedium  and  in outer 
enamel epithelium the number of p63 positive cells decreases and only a  sporadic 
expression was evident (Figure 2). 
 
Ameloblastoma: 
 Among  the peripheral cells of ameloblastoma, the intensity of p63 
expression varies, indicating that the peripheral  cells of ameloblastoma are at 
different levels of differentiation (Figure 3). 
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Figure 1A 
 
  
Figure 1B 
 
   
Figure 1C 
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Figure 1D 
 
  
Figure 1E 
 
  
Figure 1F 
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Figure 1G 
  
Figure 1H 
Figure 1: A shows the p63 expression in early bell stage tooth germ (x2 
magnification). B. shows the p63 expression in the inner enamel epithelium, 
stratum intermedium, stellate reticulum  and outer enamel epithelium of early 
bell stage tooth germ (x4 magnification). C. shows the p63 expression in cervical 
loop region (x40 magnification). D. shows the p63 expression in preameloblasts 
(x40 magnification).E. shows the p63 expression in transitional presecretory 
ameloblasts (x40 magnification). C,D,E,F.  showing the  p63 positivity decreasing 
in number and intensity as the cell progresses from the cervical loop to the cusp 
tip  (x40 magnification) G. shows the p63 expression in dental lamina rests(x40 
magnification).H. shows the p63 expression in tooth bud(x40 magnification) 
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Figure 2A 
 
  
Figure 2B 
 
  
Figure 2C 
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Figure 2D 
      
  
Figure 2E 
 
  
Figure 2F 
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Figure 2G 
 
Figure 2. A. shows the p63 expression in late bell stage tooth germ (x2 
magnification). B. shows the p63 expression in cervical loop region of late bell 
stage tooth germ (x40 magnification). C. shows the p63 expression in 
preameloblasts (x40 magnification). D. shows the p63 expression in transitional 
presecretory ameloblasts (x40magnification).E.shows the p63 expression in 
presecretory ameloblasts(x40 magnification). F.  shows the  p63  expression in 
secretory ameloblasts. B,C,D,E,F shows p63 positivity decreasing in intensity as 
the cell progresses from the cervical loop to the cusp tip  (x40 magnification) G. 
shows the sporadic p63 expression in outer enamel epithelium and intense p63 
expression in proliferating cells of the tooth bud.(x40 magnification).  
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Figure 3A 
 
  
Figure 3B 
 
  
Figure 3C 
                                                                                                     Results 
 
 Page 50 
 
  
Figure 3D 
     
Figure 3E 
Figure 3: A shows p63 expression in peripheral cells of ameloblastoma some stained 
intense and some stained mild  (x4 magnification) B. shows mild p63 expression in 
peripheral cells showing morphology of presecretory ameloblasts (x10 
magnification).C shows intense p63 expression in the undifferentiated cells and 
moderate p63 expression in the peripheral cells (x10 magnification).D. shows mild 
p63 expression in peripheral cells showing morphology of secretory ameloblasts (x10 
magnification).  E. D in (x40 magnification). 
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Expression of amelogenin in human tooth germ and ameloblastoma 
Early bell stage: 
 No  expression of amelogenin was detected in the enamel organ and dental 
papilla cells except for a mild reaction in the dental follicle cells in all the six 
EBS’s evaluated in the current study (Figure 4). 
 
Late bell stage 
 Immunohistochemical expression of amelogenin was first evident at the 
presecretory ameloblasts at the cusp tip before enamel matrix secretion and the 
expression in these cells became negative once the enamel matrix is secreted, but 
by this time the secretory ameloblasts begin to react intensively with amelogenin 
(Figure 5). 
 
 The expression of amelogenin  in the secretory ameloblast starts at the 
cusp tip and progresses cervically and was evident only in five of the fifteen late 
bell stages studied.  In ten LBS’s the expression of amelogenin in  the secretory 
ameloblasts was negative and in some cases granular positivity of amelogenin was 
evident at the tomes process (Figure 6,7). 
 
 Enamel matrix stains intensively with amelogenin with more intense 
staining at the DEJ  in all the late bell stages studied. Mild expression of 
amelogenin was evident at the dentinal tubules near the  forming enamel matrix 
(Figure 7). 
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 No expression of amelogenin was evident at the dental papilla cells or 
odontoblasts, stratum intermedium and stellate reticulum cells  throughout 
odontogenesis. Mild expression of amelogenin was evident at the dental follicle 
and condensing mesenchyme around bud. Expression of amelogenin was also 
evident at the differentiated cells of oral epithelium and in the central squamous 
cells of  the tooth bud (Figure 6). 
 
 In addition, expression of amelogenin was also evident in the condensing 
mesenchyme around bone forming region, osteoid matrix, osteoblasts, osteocytes, 
differentiated cells of skin epithelium and hair follicles. In general cartilage was 
negative, but for a mild reaction in the perichondrial cells (Figure 8). 
 
Ameloblastoma: 
 Out of fifteen cases studied, immunohistochemical expression of 
amelogenin was  absent in eleven cases of ameloblastoma, but in four cases, 
expression of amelogenin was evident in the cytoplasm of peripheral cells of 
ameloblastoma (Figure 9). 
 
 In addition to this, in three cases  amelogenin expression was evident in 
the collagen fibres located around the follicles in ameloblastoma, which was 
further confirmed by massons trichrome special stain (stains collagen fibres blue). 
Amelogenin expression was also evident at the follicles of ameloblastoma 
showing central squamous differentiation (Figure 10). 
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Figure 4A 
 
    
Figure 4B 
 
Figure 4: A shows amelogenin expression in early bell stage tooth germ (x2 
magnification). B. Shows mild expression of amelogenin in the dental follicle 
cells (x4 magnification). 
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Figure 5 A 
 
   
Figure 5 B 
 
   
Figure 5 C 
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Figure 5D 
 
   
Figure 5 E 
 
Figure 5 : A Shows the late bell stage tooth germ with only dentin formation 
at the cusp tip.(x2 magnification) B. A in (x4 magnification). C. shows mild 
expression of amelogenin in presecretory ameloblasts at the cusp tip (x40 
magnification). D.Shows intense expression of amelogenin in the secretory 
ameloblasts and also shows secretion of enamel matrix at the cusp tip (x10 
magnification). E. D (in x40 magnidication) 
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Figure 6A 
 
   
Figure 6B 
 
   
Figure 6C 
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Figure 6D 
 
Figure 6: A shows amelogenin expression in late bell stage tooth germ and it’s 
associated structures(x2 magnification). B shows intense expression of 
amelogenin in the enamel matrix (x10 magnification). C shows moderate 
expression of amelogenin in the secretory ameloblasts progressing 
cervically(x40 magnification). D shows mild expression of amelogenin in the 
central squamous cells of the bud and condensing mesenchyme around 
bud(x40 magnification). 
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Figure 7A 
 
  
Figure 7B 
 
  
Figure 7C 
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Figure 7D 
 
Figure 7: A Shows expression of amelogenin in two late bell stage tooth germs 
(x2 magnification).B. Shows intense staining of amelogenin in the enamel 
matrix (x40 magnification). C. Shows moderate amelogenin expression  at the 
tomes process and absence of amelogenin expression in the secretory 
ameloblasts and mild expression of amelogenin at the dentinal tubules (x40 
magnification). D. Shows absence of expression of  amelogenin  in the 
secretory ameloblasts at the matrix forming end (x40 magnification). 
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Figure 8A 
 
  
Figure 8B and 8C 
 
Figure 8: A shows expression of amelogenin in the condensing mesenchyme 
around bone, osteoid matrix, osteoblasts and some osteocytes(x40 magnification). 
B Shows expression of amelogenin in the differentiated cells of skin epithelium 
and hair follicles (x40 magnification). C Shows expression of amelogenin in the 
condensing mesenchyme around cartilage(x40 magnification). 
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Figure 9 A 
 
   
Figure 9 B 
 
Figure 9: A shows mild expression of amelogenin in the peripheral cells of 
ameloblastoma showing morphology of presecretory ameloblasts (x40 
magnification). B. shows intense expression of amelogenin in the peripheral cells 
of ameloblastoma showing morphology of secretory ameloblasts (x40 
magnification).                                                                                
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Figure 10 A 
 
   
Figure 10 B and 10 C 
 
Figure 10: A shows amelogenin expression in the follicles of ameloblastoma 
showing central squamous differentiation and in the connective tissue around the 
follicles(x4 magnification).B shows A  stained with masson’s trichrome  (stains 
collagen fibres blue) (x4 magnification). C shows  expression of amelogenin in 
connective tissue around the follicles of ameloblastoma (x10 magnification). 
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                                                 DISCUSSION 
Previous studies have mentioned that basal cells are composed of  heterogenous cell 
population  and p63 is expressed only by the cells that possesss the ability to proliferate.  Strong  
p63 expression is restricted to keratinocyte stem cells and the transit- amplifying cells after their 
withdrawal from the stem cell compartment show reduced p63 expression even though they 
possess appreciable proliferative capacity (13,14). Similar to this study we also found strong p63 
expression in some of the basal cells of oral epithelium and as the cells differentiate and move 
upward we noticed reduced p63 expression.   
Pindborg 1959 (58) divided the enamel organ of rat into five main sectors histologically, 
extending from the epithelial loop till the fusion with the gingival epithelium. Among the five 
main sectors, the first sector comprises the proliferative zone of odontogenic epithelium which 
extends from the cervical loop (junction of outer enamel epithelium and inner enamel 
epithelium) to the point where dentin formation begins and is characterized by  rapid mitotic 
activity of undifferentiated ameloblasts.  During the early bell stage we noticed intense p63 
expression in the cervical loop region and as the cell progresses from the cervical loop to the 
cusp tip, both  the intensity  and number of p63 positive cells decreases. After the formation of 
enamel and dentin i.e, during the late bell stage, intense p63 expression was evident only in the 
cervical loop region, which revealed that cervical loop region might be the stem cell 
compartment of tooth germ. 
  Our results in late bell stage tooth germ were consistent with the results of  Laurikkala et 
al. (16) who found out that  the intensity of  p63 expression decreases when the inner enamel 
epithelium differentiated into ameloblasts. p63 expression was evident throughout 
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odontogenesis, although the intensity of expression varies suggesting that p63 might play a role 
in tooth formation. 
There are so many studies which showed that p63 is expressed in the basal and 
suprabasal layers of  cystic ameloblastoma, peripheral and central stellate reticulum-like cells of 
conventional ameloblastoma (3,5,18,21,22,23). In addition to this, we noticed that the intensity 
of p63 expression varies in the peripheral cells of ameloblastoma  suggesting that peripheral cells 
are at different levels of differentiation yet maintaining their proliferative capacity. 
Nel et al. (45) suggested that amelogenin expression  was not found during  the bud, cap  
and early bell stages of tooth development in dog by immunohistochemistry. But, during the late 
bell stage small amounts of amelogenin expression was observed  in the presecretory ameloblasts 
in close approximation to the cell nucleus. Similar to this study we didn’t observe any 
amelogenin expression during the bud, cap and early bell stages of tooth development and during 
the late bell stage, amelogenin expression was evident in the presecretory ameloblasts at the cusp 
tip.  
The expression of amelogenin was first detected at the presecretory ameloblasts before 
enamel matrix secretion (25). Amelogenin expression was first detected at the presecretory 
ameloblasts and the expression was limited to secretory ameloblasts once the enamel matrix is 
secreted (28). As the first evidence of amelogenin protein expression was  also detected in the 
presecretory ameloblasts at the cusp tip in the current study, it  is suggested that amelogenin 
mRNA expression  might also be evident  in presecretory ameloblasts at the cusp tip before the 
onset of biomineralization. 
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Amelogenin mRNA expression was  first detected at the cusp tip and ceases at the 
cementoenamel junction (40). Amelogenin protein expression was absent during the early bell 
stage and noted only during the late bell stage (45). By in situ hybridization AMEL expression 
was first detected in the secretory ameloblasts located at the cusp tip during early enamel matrix 
deposition.  But, during the maturation stage AMEL expression was absent  in the ameloblasts at 
the tooth tip but was present in the ameloblasts towards the tooth base, in which enamel matrix 
was still deposited (48). Immunohistochemiclly amelogenin protein expression was first detected 
at the secretory ameloblasts and ceases when the enamel begins to mature (49).  Amelogenin 
protein expression in the current study was first detected at the cusp tip and the secretion 
progresses cervically towards the cementoenamel junction.  
We observed the formation of enamel matrix progressing cervically but, we observed 
immunostaining in the secretory ameloblasts  only  in five LBS tooth germs, out of fifteen LBS’s  
evaluated  in the current study.  
The immunonegativity of secretory ameloblasts might be due to small amount of 
amelogenin secretion and the synthesized amelogenins are below the sensitivity of 
immunolocalisation techniques  or inability of the antibody to detect the amelogenin which is 
secreted by secretory ameloblast. During amelogenesis, clock genes (Bmal 1, Clock, Per 1, Per 
2) direct ameloblast function by controlling several ameloblast-specific genes including 
amelogenin (marker of secretory ameloblasts) and klk4 (marker of maturation ameloblasts) at 
RNA and protein level. It is suggested that amelogenin and klk4 undergo a regular 24 hr 
oscillations and result in significant alterations in enamel apposition and mineralization and this 
circadian rhythm was evident in the human enamel as  cross-striations traversing enamel prisms 
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(47). The change in the expression pattern of clock genes might also be the reason for the 
immunonegativity in the secretory ameloblasts.  
  Ameloblasts synthesize cytokeratins 5 and 14 along with several matrix proteins. Studies 
showed that tri tyrosyl motif of N- terminal region of amelogenin binds to N acetyl glucosamine 
(GlcNAc). N acetyl glucosamine (GlcNAc) mimicking peptide was  localized in the highly 
conserved N-terminal domain of cytokeratins 14, 16, and 17.   Amelogenin is translocated from 
the site of synthesis in the perinuclear region to the apical region of the cell in association with 
CK14, and at the apical region (Tomes process) the dissociation of the co-assembly complex of 
CK14-amelogenin occur, prior to amelogenin secretion (32,33). Only free amelogenin proteins 
could be detected by immunohistochemistry. Since amelogenin is bonded  to CK14 
intracellularly and the dissociation of the CK14-amelogenin complex occurs at the tomes 
process, this might be the reason that it is not detected  in the secretory ameloblasts. 
 
The MMP-20 (matrix metalloproteinase-20) or enamelysin is secreted along with 
amelogenins and other structural proteins such as ameloblastin and enamelin during the secretory 
stage and it begins to cleave the enamel proteins (59).  In human tooth germ, during it’s 
development amelogenin labeling was more in the enamel organ than enamelysin during the 
early bell stage and enamelysin labeling was more in the enamel organ  than amelogenin during 
the late bell stage (7). During early bell stage,  a colocalization of amelogenin and enamelysin  
proteins were found  inside the Golgi apparatus with amelogenin being more evident in relation 
with golgi complex and  during late bell stage, a colocalization of both proteins was found in the 
rough endoplasmic reticulum with enamelysin being more noticeable in relation with rough 
endoplasmic reticulum (8). This study demonstrates that both secretion and maturation of 
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amelogenin go hand in hand during amelogenesis. Because enamelysin is secreted more than 
amelogenin during late bell stage, this might be the reason that amelogenin is not detected in the 
secretory ameloblasts by immunolocalisation techniques. Further studies in this regard in human 
tooth germ are encouraged. 
 
 Expression of amelogenin in dentinal tubules depends upon the secretory capacity of SA. 
If the SA secretes more, it will spread out through channels in dentin to coat the lateral and distal 
surfaces of odontoblasts. The concentration decreases gradually as the amelogenin spread out 
further from the point of secretion (60). The distribution of first amelogenins secreted onto the 
dentinal tubules suggest that these proteins could perform a signaling function. Migration of 
enamel protein toward the dental pulp and odontoblasts plays a role in the interaction between 
ameloblasts and odontoblasts (25). 
 
Oida et al. (35) suggested that secretory ameloblasts express amelogenin 1000 times  
more than odontoblasts. The author also suggested that the positive reaction in the odontoblasts 
was because of the 1000 times stronger reaction in the nearby secretory stage ameloblasts. Ye et 
al. (42) suggested that amelogenin expression was evident in the forming dentin of a developing 
tooth germ where enamel matrix formation had not been initiated  yet and also in  the 
odontoblast layer of  the adult human dentin by in situ hybridization, immunohistochemistry and 
other techniques. Throughout the present study we didn’t observe expression of amelogenin in 
the odontoblasts. But we observed mild staining of amelogenin  in the dentinal tubules. It was 
suggested that staining of amelogenin in the dentinal tubules could be due to background staining  
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Mitsiadis et al. suggested that  zebra like pattern of amelogenin protein distribution was 
observed  in human tooth germ (two amelogenin positive layers at the ends splitted by an 
amelogenin negative zone). This  pattern of amelogenin protein distribution in the enamel could 
be due to differential  processing of amelogenin during the secretory stage (6).  We observed 
intense staining of amelogenin in the enamel matrix of  all late bell stage tooth germs with more 
intense staining at the DEJ. Intense staining at the DEJ in all LBS’s studied might be due to 
intimate contact between enamel and dentin.  
We  also  noticed  expression of amelogenin in the  condensing mesenchyme around bud, 
dental follicle cells and  condensing mesenchyme around bone and cartilage. The reason for this 
is unknown but, this suggested that amelogenin was not an enamel specific protein rather a 
multifunctional protein (44). We also noticed ameligenin expression in the differentiated cells of 
keratinized oral epithelium, central squamous cells  of the tooth bud. Amelogenin cross reaction 
with keratin polypeptides was confirmed by immunoblotting technique. This might be due to the 
similarities in the antigenic sites of keratin and amelogenin (54). 
Amelogenin mRNA and protein has a very important role in the processes of bone 
development and remodeling. Amelogenin play a role in the induction of osteogenesis and 
inhibition of osteoclastogenesis.   Amelogenin  was  found to be  expressed in long bone 
periosteum, which is composed of progenitor cells, bone marrow cells, osteoblasts and 
osteoclasts lining the bone trabeculae and by some osteocytes. Amelogenin protein was also 
found to be expressed in  articular cartilage chondrocytes, epiphyseal bone cells  and 
differentially in specific cell layers of the epiphyseal growth plate (43). Similar to this study, we 
also noticed expression of amelogenin  in the condensing mesenchyme around bone forming 
region, osteoid matrix, osteoblasts, some osteocytes and in the perichondrial cells. 
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Although the peripheral cells of ameloblastoma nests mimics the normal inner enamel 
epithelium from the bud to bell stages of human tooth germ, they do not attain differentiation as 
secretory ameloblasts in amelogenesis (54). This might account for the absence of amelogenin 
expression in the peripheral cells of ameloblastoma in eleven of the fifteen case studied. 
Previous studies also indicated that  only one strand of amelogenin gene was transcribed 
during the normal development of tooth whereas both strands of human amelogenin gene were 
transcribed in ameloblastoma. Ameloblastoma cells contain antisense mRNA  transcribed from 
the opposite strand of an amelogenin gene. Antisense mRNA  bind with the sense strand of 
mRNA, thereby prevents it from being translated to protein and this might account for the 
inability of the tumor cells to produce matrix (53). 
Expression of amelogenin was evident in the peripheral cells of ameloblastoma (four out 
of fifteen cases studied) demonstrating presecretory and secretory morphology suggesting that 
ameloblastoma attained functional maturation beyond the presecretory stage (10). This also 
suggested that some matrix proteins were formed intracellularly but it could not be processed or 
released appropriately. And also enamel matrix secretion by ameloblasts has been found to be 
dependent on precedent dentinogenesis which was absent in ameloblastoma (54). 
Amelogenin immunoreactivity was evident in the collagen fibres located around the 
follicles of ameloblastoma in three cases, which was further confirmed by massons trichrome 
special stain (stains collagen fibres blue) and at the follicles of ameloblastoma showing central 
squamous differentiation. The reason for this is unknown. This might be due to the similarities in 
the antigenic sites of keratin and amelogenin (54) or cross reaction between the antigenic sites of 
any other molecules and amelogenin. 
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We also observed that different detection kits and different concentrations of primary 
antibody resulted in slightly different expression pattern in the enamel organ. So it was important 
to keep the methodology as consistent as possible. Previous studies indicated that antigen 
preservation was depended on the type of fixation and decalcification. Throughout the present 
study all these parameters were kept constant. 
Limitations of the study: 
As amelogenin is a research marker, a number of dilution threshold is required to 
determine ideal dilutions. This will invariably result in shortage of the marker for the study. In 
the present study, the reaction at various dilutions are noted as follows 
 At dilution 1:25, 1:50  and 1:80 in PBS, the expression was evident throughout the 
enamel organ from the inner enamel epithelium, preameloblast, presecretory and 
secretory ameloblasts as well as in the stratum intermedium, stellate reticulum  and outer 
enamel epithelium with the nuclear and cytoplasmic staining pattern although the 
intensity of staining decreases when the dilution increases. Enamel matrix was not 
stained as intense as the cells of the enamel organ. Expression was also noted in the 
odontoblasts, dental papilla cells and dental follicle cells. In addition, we also noted 
expression in other connective tissue components which was considered to be 
background staining. 
 At dilution 1:100, 1:120 and 1:150 in PBS, the expression was evident in the enamel 
organ from the preameloblast, presecretory and secretory ameloblasts as well as in the 
stratum intermedium and stellate reticulum cells with predominantly cytoplasmic and 
focal nuclear staining pattern. Enamel matrix stained intensely in all the dilutions. 
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Expression was also noted in the odontoblasts and the peripheral condensed dental papilla 
cells in the region of the cusp tip. In the dental follicle the expression was restricted to the 
region of cervical loop and diaphragm. In addition, we also noted expression in other 
connective tissue components which we believe as background staining. 
 At dilution 1:180 in PBS, the expression was evident in the enamel organ from 
presecretory and secretory ameloblasts with only the cytoplasmic staining pattern. 
Enamel matrix stained intensely similar to 1:100, 1;120, 1;150 dilutions. A focal 
expression was seen in the stratum intermedium cells and a very mild expression was 
detected in the odontoblasts and the peripheral condensed dental papilla cells in the 
region of the cusp tip. In the dental follicle the expression was restricted to the region of 
cervical loop and diaphragm. In addition, we also noted mild expression in other 
connective tissue components which we believe as  background staining. 
  At dilution 1:200 in PBS, expression was evident only in the presecretory, secretory 
ameloblasts and in the enamel matrix. No expression was detected in the other cells of the 
enamel organ. The dental papilla cells and odontoblasts are negative except for a focal 
reaction in the dental follicle. No background staining was evident in this dilution in the 
connective tissue components. 
Polyclonal antibody has the affinity to bind to different epitopes of the same antigen. 
Since amelogenin used in this study is polyclonal in nature, it cross reacts with other molecules 
when it recognizes similar epitopic sites, which could be the reason for its expression in the oral 
epithelium in the current study.                                  
                                                                                                            Figure Legends 
 
 Page 72 
 
                                                 FIGURE LEGENDS 
Figure 1: A shows the p63 expression in early bell stage tooth germ (x2 magnification). B. 
shows the p63 expression in the inner enamel epithelium, stratum intermedium, stellate reticulum  
and outer enamel epithelium of early bell stage tooth germ (x4 magnification). C. shows the p63 
expression in cervical loop region (x40 magnification). D. shows the p63 expression in 
preameloblasts (x40 magnification). E. shows the p63 expression in transitional presecretory 
ameloblasts (x40 magnification). C,D,E,F.  showing the  p63 positivity decreasing in number and 
intensity as the cell progresses from the cervical loop to the cusp tip  (x40 magnification) G. 
shows the p63 expression in dental lamina rests (x40 magnification).H. shows the p63 expression 
in tooth bud(x40 magnification). 
 
Figure 2. A. shows the p63 expression in late bell stage tooth germ (x2 magnification). B. shows 
the p63 expression in cervical loop region of late bell stage tooth germ (x40 magnification). C. 
shows the p63 expression in preameloblasts (x40 magnification). D. shows the p63 expression in 
transitional presecretory ameloblasts (x40magnification).E.shows the p63 expression in 
presecretory ameloblasts(x40 magnification). F.  shows the  p63  expression in secretory 
ameloblasts. B,C,D,E,F shows p63 positivity decreasing in intensity as the cell progresses from 
the cervical loop to the cusp tip  (x40 magnification) G. shows the sporadic p63 expression in 
outer enamel epithelium and intense p63 expression in proliferating cells of the tooth bud.(x40 
magnification).  
 
Figure 3: A shows p63 expression in peripheral cells of ameloblastoma some stained intense and 
some stained mild  (x4 magnification) B. shows mild p63 expression in peripheral cells showing 
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morphology of presecretory ameloblasts  (x10 magnification).C shows intense p63 expression in 
the undifferentiated cells and moderate p63 expression in the peripheral cells (x10 
magnification).D. shows mild p63 expression in peripheral cells showing morphology of 
secretory ameloblasts (x10 magnification).  E. D in (x40 magnification). 
Figure 4: A shows amelogenin expression in early bell stage tooth germ (x2 magnification). B. 
Shows mild expression of amelogenin in the dental follicle cells (x4 magnification). 
Figure 5 : A Shows the late bell stage tooth germ with only dentin formation at the cusp tip.(x2 
magnification) B. A in (x4 magnification). C. shows mild expression of amelogenin in 
presecretory ameloblasts at the cusp tip (x40 magnification). D.Shows intense expression of 
amelogenin in the secretory ameloblasts and also shows secretion of enamel matrix at the cusp 
tip (x10 magnification). E. D (in x40 magnification). 
Figure 6: A shows amelogenin expression in late bell stage tooth germ and it’s associated 
structures(x2 magnification). B shows intense expression of amelogenin in the enamel matrix 
(x10 magnification). C shows moderate expression of amelogenin in the secretory ameloblasts 
progressing cervically(x40 magnification). D shows mild expression of amelogenin in the central 
squamous cells of the bud and condensing mesenchyme around bud(x40 magnification). 
Figure 7: A Shows expression of amelogenin in two late bell stage tooth germs (x2 
magnification).B. Shows intense staining of amelogenin in the enamel matrix (x40 
magnification). C. Shows moderate amelogenin expression  at the tomes process and absence of 
amelogenin expression in the secretory ameloblasts and mild expression of amelogenin at the 
dentinal tubules (x40 magnification). D. Shows absence of expression of  amelogenin  in the 
secretory ameloblasts at the matrix forming end (x40 magnification). 
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Figure 8: A shows expression of amelogenin in the condensing mesenchyme around bone, 
osteoid matrix, osteoblasts and some osteocytes(x40 magnification). B Shows expression of 
amelogenin in the differentiated cells of skin epithelium and hair follicles (x40 magnification). C 
Shows expression of amelogenin in the condensing mesenchyme around cartilage(x40 
magnification). 
Figure 9: A shows mild expression of amelogenin in the peripheral cells of ameloblastoma 
showing morphology of presecretory ameloblasts (x40 magnification). B. shows intense 
expression of amelogenin in the peripheral cells of ameloblastoma showing morphology of 
secretory ameloblasts (x40 magnification).    
Figure 10: A shows amelogenin expression in the follicles of ameloblastoma showing central 
squamous differentiation and in the connective tissue around the follicles(x4 magnification).B 
shows A  stained with masson’s trichrome  (stains collagen fibres blue) (x4 magnification). C 
shows  expression of amelogenin in connective tissue around the follicles of ameloblastoma (x10 
magnification). 
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                                                 SUMMARY AND CONCLUSION 
 The present study was undertaken to evaluate the expression of p63 and amelogenin in 
human tooth germs and ameloblastomas by immunohistochemistry to find out whether the 
pattern of expression is related to differentiation of ameloblasts. 
Six unclaimed dead fetal tissues from 13th to 24th week were collected from Institute of 
Obstetrics and Gynaecology, Chennai  with prior permission. Jaws were dissected  from these 
dead fetal tissues  and were decalcified in 8% HCl for one hour, fixed in 10% formalin, 
dehydrated, embedded in wax block,  sectioned sagitally in the thickness of 3.5 microns and 
stained with H&E for histological observation.  Archival samples of different histological 
variants of ameloblastoma were retrieved from Department of Oral Pathology and Microbiology, 
Tamil Nadu Government Dental College and Hospital, Chennai and sectioned  in 3.5 microns 
thickness and stained with H&E for histological observation. 
Accordingly, histologically confirmed 15 human tooth germs of late bell stage, 6 human 
tooth germs of early bell stage and 15 ameloblastoma samples were included in the study. 
Immunohistochemical staining was performed with the following markers, p63  antibody 
(Mouse Monoclonal, clone 4A4, 1:25 dilution, CM163 – BioCare, USA) and AMELX antibody 
(Rabbit Polyclonal, 1:200 dilution, orb140077 – Biorbyt, UK) diluted in PBS, foetus tissue 
sections and  ameloblastoma sections mounted on APES coated glass slides as per 
manufacturer’s instructions and assessed individually. 
During the early bell stage, p63 expression was intense throughout the enamel organ. But, 
during the late bell stage, the number and intensity of p63 expression decreases in the cells of 
enamel organ. The peripheral cells in the ameloblastoma shows variable pattern of p63 
                                                                                            Summary and Conclusion 
 
 Page 76 
 
expression i.e., some nuclei stained intense and some stained mild. Expression of amelogenin 
was first evident in the presecretory ameloblasts at the cusp tip, followed by secretory 
ameloblasts  and  progresses cervically. But in ten late bell stage tooth germs, amelogenin 
expression was negative in the secretory ameloblasts and positive only at the secreting end i.e. 
tomes process.  Intense staining was evident at the enamel matrix and in some dentinal tubules 
nearer to secretion of enamel matrix. No amelogenin expression was evident in the dental papilla 
cells or odontoblasts throughout odontogenesis with the exception of dental follicle. Amelogenin 
expression was absent in eleven cases of ameloblastoma, but in four cases positive expression 
was evident at the peripheral cells showing presecretory and secretory morphology suggesting 
that ameloblasts attained differentiation beyond the presecretory stage. 
              The present study concluded that expression pattern of p63 and amelogenin in human 
tooth germ was found to be consistent with ameloblastoma. p63 was considered to be a 
proliferation marker whereas amelogenin was considered to be a differentiation marker.  
Amelogenin expression was evident only in ameloblasts which show negative or mild  
p63 expression. Hence downregulation of p63 expression was associated with ameloblast 
differentiation. 
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